Full Text

Turn on search term navigation

© 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Understanding the dependence of the induction of genomic instability on the linear energy transfer (LET) and the dose of the charged particles is critical in order to accurately assess the cancer risks from exposures during long-term space missions to the Moon or Mars [1,2]. Current cancer risk projections for cosmic ray proton and HZE particle exposures are extrapolated from high dose γ-rays derived from human epidemiology data using quality factors and the dose and dose-rate reduction effectiveness factor (DDREF), assuming a linear no-threshold dose response. [...]relative biological effectiveness (RBE) factors for chromosomal aberrations are similar to RBEs observed for induction of solid tumors in mice [4,6,7]. [...]CA may continue to remain as a useful biomarker for cancer risks and for comparisons with other biomarkers in the absence of human data for galactic cosmic rays [1,8]. Since the assumption of a linear dose response for biological effects of high-LET radiation is fundamental in radiation protection methodologies, our recent findings could have a major impact on current risk assessment predictions for astronauts.

Details

Title
Nitric Oxide Is Involved in Heavy Ion-Induced Non-Targeted Effects in Human Fibroblasts
Author
Hada, Megumi; Saganti, Premkumar B; Cucinotta, Francis A
Publication year
2019
Publication date
2019
Publisher
MDPI AG
ISSN
16616596
e-ISSN
14220067
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2333826587
Copyright
© 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.